瑞士纳沙泰尔–(BUSINESS WIRE)–(美国商业资讯)–SAV-IOL（Swiss Advanced Vision）正在推进R-TASC项目的开发，这是首款具备实时自动对焦的电子人工晶体(IOL)，旨在完全恢复白内障手术后的视力。R-TASC即将在今后5-7年内拓展眼科领域的疆界。SAV-IOL已验证了该项目的技术可行性，现在正寻求筹集2千万美元将这一突破性器械推向市场。 尽管人工晶体市场广阔，但自其问世以来鲜有可观的创新。此外，现时的人工晶体一直受制于一些视光学缺陷，例如视力调节范围…
Author: Business Wire
技術可行性獲得成功後，瑞士公司SAV-IOL現在正為用於白內障手術的智慧主動式人工水晶體專案尋求投資者
瑞士納沙泰爾–(BUSINESS WIRE)–(美國商業資訊)–SAV-IOL（Swiss Advanced Vision）正在推進R-TASC專案的開發，這是首款具備即時自動對焦的電子人工水晶體(IOL)，旨在完全恢復白內障手術後的視力。R-TASC即將在今後5-7年內挑戰眼科領域的極限。SAV-IOL已確認該專案的技術可行性，現在正尋求籌集2千萬美元將這一突破性器材推向市場。 儘管人工水晶體市場廣闊，但自其問世以來鮮有可觀的創新。此外，現時的人工水晶體一直受制於一些視光學缺陷，例如視力調節…
Após a viabilidade técnica bem-sucedida, a empresa suíça SAV-IOL está agora em busca de investidores para o projeto de lentes intraoculares ativas inteligentes para cirurgia de catarata
NEUCHATEL, Suíça–(BUSINESS WIRE)–A SAV-IOL (Swiss Advanced Vision) está avançando no desenvolvimento do Projeto R-TASC, a primeira lente intraocular eletrônica (LIO) com autofoco em tempo real, destinada a restaurar totalmente a visão após a cirurgia…
Riassunto: Dopo il successo della fattibilità tecnica, la società svizzera SAV-IOL sta ora cercando investitori per il progetto lente intraoculare smart attiva per interventi di cataratta
NEUCHATEL, Svizzera–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) sta andando avanti con lo sviluppo del Progetto R-TASC, la prima lente intraoculare (IOL) elettronica autofocalizzante in tempo reale, finalizzata a ristabilire completamente la vista in fase di post-intervento di cataratta. R-TASC intende rivoluzionare il settore dell’oftalmologia nei prossimi 5-7 anni. SAV-IOL ha già confermato la fattibilità tecnica di questo progetto e ora sta cercando di raccogliere 20 milioni di dollari
Luego del éxito de la viabilidad técnica, la empresa suiza SAV-IOL está ahora buscando inversores para un proyecto de lentes intraoculares activos inteligentes para cirugía de cataratas
NEUCHATEL, Suiza–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) está avanzando con el desarrollo del proyecto R-TASC, los primeros lentes intraoculares electrónicos (IOL) con enfoque automático en tiempo real, que tiene por objetivo restaurar comple…
Samenvatting: Na gebleken succesvolle technische haalbaarheid is het Zwitserse bedrijf SAV-IOL op zoek naar investeerders voor het Smart Active Intraocular Lens Project voor cataractchirurgie
NEUCHATEL, Zwitserland–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) gaat verder met de ontwikkeling van het R-TASC-project, de eerste elektronische intraoculaire lens (IOL) met real-time autofocus, die tot doel heeft het zicht na een cataractopera…
Après des essais de faisabilité technique fructueux, la société suisse SAV-IOL est actuellement à la recherche d'investisseurs pour un projet de lentille intra-oculaire intelligente active pour l’opération de la cataracte
NEUCHATEL, Suisse–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) progresse dans le développement du projet R-TASC, la première lentille intraoculaire électronique (LIO) avec autofocus en temps réel, destiné à restaurer complètement la vision après l…
Aerie Pharmaceuticals Upsizes and Prices Private Offering of $275 Million 1.50% Convertible Senior Notes Due 2024
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced today that it has…
Riassunto: Immervision presenta la nuova lente panomorfica Super Wide-Angle 125° FoV con la più alta risoluzione per smartphone
MONTREAL–(BUSINESS WIRE)–Immervision, lo sviluppatore e licenziatario di tecnologia ottica e di imaging grandangolare brevettata annuncia il primo campo visivo (FoV) da 125° super grandangolare del settore con la lente panomorfica a più alta risoluzione e nitidezza d’immagine da un bordo all’altro per smartphone e produttori di fotocamere per consumatori. Il nuovo licenziatario della lente super grandangolare brevettata di Immervision, l’azienda taiwanese Zhong Yang Technology Co., Ltd. (JMO)
Immervision lance un nouvel objectif panomorphe 125° à angle très large avec la plus haute résolution pour Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, la société montréalaise qui développe et concède sous licence des technologies brevetées d’optique grand angle et d’imagerie, annonce la première technologie à très grand angle de l’industrie, doté d’un champ de vision (FoV) de 125° avec la plus haute résolution et la plus grande clarté d’image grâce à l’objectif panomorphe bord à bord pour les fabricants de smartphones et de caméras grand public. Le nouveau titulaire de la licence de l’objectif grand ang
Immervision stellt neues panomorphes Superweitwinkel-Objektiv mit einem Bildwinkel von 125° und höchster Auflösung für Smartphones vor
MONTREAL–(BUSINESS WIRE)–Immervision, der Entwickler und Lizenzgeber patentierter Weitwinkel-Optik- und Bildgebungstechnologie mit Sitz in Montréal, kündigt das branchenweit erste panomorphe Superweitweitwinkel-Objektiv mit einem Bildwinkel von 125° …
My Eyelab, a Leading Eye Health Provider, Plans Retail Expansion in Houston Area with 10 New Locations by 2020
HOUSTON–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/EyeExam?src=hash" target="_blank">#EyeExam</a>–My Eyelab, a Leading Eye Health Provider, Plans
Retail Expansion in Houston Area with 10 New Locations by 2020
My Eyelab, Proveedor Líder de Salud Oftalmológica, Planea una Expansión de Tiendas Minoristas en el Área de Houston con 10 Nuevas Sucursales para 2020
HOUSTON–(BUSINESS WIRE)–My Eyelab, una marca minorista de Now Optics, es un proveedor líder de salud oftalmológica que ofrece servicios para el cuidado de la vista y lentes accesibles y económicos, anunció hoy la expansión de su presencia minorista e…
IVERIC bio to Host Inaugural Gene Therapy R&D Investor Day on September 13, 2019
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that it will host its inaugural Gene Therapy R&D Investor Day in New York on Sept. 13, 2019, from 8:30 a.m. to 11:30 a.m. ET.
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
STAAR Surgical Announces Strategic Alliance Agreement with Asian Eye Institute
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it has entered a strategic alliance with …
Aerie Pharmaceuticals to Offer $250 Million Convertible Senior Notes Due 2024
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…